NCT01586845View on ClinicalTrials.gov

Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Renal Transplantation
Interventions
DRUG

voclosporin

Initial dose of voclosporin 0.8 mg/kg BID, then concentration controlled

DRUG

tacrolimus

tacrolimus as per labeled dose

Sponsors
All Listed Sponsors
lead

Aurinia Pharmaceuticals Inc.

INDUSTRY

NCT01586845 - Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation | Biotech Hunter | Biotech Hunter